Analyst Stock Ratings Downgrades

Analyst downgrades are often a bearish signal for a stock. When an analyst downgrades a stock it means the stock rating is lower than it previously was and the analyst likely does not recommend people buy the stock. Updated 09/18/2024

Data brought to you by Benzinga APIs

Recent Analyst Stock Rating Downgrades News

Evaluating TG Therapeutics: Insights From 4 Financial Analysts
Forecasting The Future: 6 Analyst Projections For Corcept Therapeutics
Key Takeaways From PayPal Holdings Analyst Ratings
In-Depth Examination Of 5 Analyst Recommendations For Wyndham Hotels & Resorts
Apple Expands Beyond China To India, Southeast Asia, Analyst Warns Of Margin Impact
Apple is diversifying production away from China to India and Southeast Asia. Hon Hai and Luxshare will benefit, but hurdles remain in component supply.
Wells Fargo Maintains Overweight on Ferguson Enterprises, Lowers Price Target to $225
Wells Fargo analyst Sam Reid maintains Ferguson Enterprises (NYSE:FERG) with a Overweight and lowers the price target from $250 to $225.
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
JMP Securities has initiated coverage on BeiGene highlighting the Chinese biotech company as a 'unique investment opportunity.' The firm's leading drug, Brukinsa (zanubrutinib), is emerging in the competitive BTK inhibitor market.
Jefferies Maintains Buy on Corpay, Raises Price Target to $375
Jefferies analyst Trevor Williams maintains Corpay (NYSE:CPAY) with a Buy and raises the price target from $350 to $375.
Jefferies Maintains Buy on CubeSmart, Raises Price Target to $62
Jefferies analyst Jonathan Petersen maintains CubeSmart (NYSE:CUBE) with a Buy and raises the price target from $53 to $62.
Here's Why You Should Retain Xylem Stock in Your Portfolio for Now
Xylem Inc. (NYSE: XYL) is well-poised for growth in the coming quarters, courtesy of its businesses and accretive acquisitions. The company's efforts to reward its shareholders add to its appeal.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free